Evidence map›Paper›PMID 34624553›Full record

ReviewTravel medicine and infectious disease

COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series.

Abdel-Naser Elzouki, Maab A M Osman, Mohanad A E Ahmed, Abdulrahman Al-Abdulmalek, Mohammad Altermanini, Haneen A Al-Ani, Muhammad Naeem, Elmukhtar Habas

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abdel-Naser ElzoukiDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar; College of Medicine, Qatar University, Qatar; Weill Cornell Medical College, Doha, Qatar. Electronic address: aelzouki@hamad.qa.
Maab A M OsmanDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Mohanad A E AhmedDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Abdulrahman Al-AbdulmalekDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Mohammad AltermaniniDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Haneen A Al-AniDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Muhammad NaeemDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar.
Elmukhtar HabasDepartment of Medicine, Hamad General Hospital, Hamad Medical Corporation, Qatar; College of Medicine, Qatar University, Qatar.
Hamad General Hospital · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/Aims: Corona virus disease 2019 (COVID 19) is a pandemic infectious disease of 2020, which often presents with respiratory and gastrointestinal symptoms. The behavior of the virus and its full clinical picture has not been fully studied yet. Many case reports and case series have been running in order to elaborate different presentations and associations. Pulmonary and gastrointestinal features of COVID-19 infection are well outlined; however, neurological manifestations are less defined. CASE PRESENTATION: We report two adult cases of COVID-19 infection presented with acute Guillain-Barre Syndrome (GBS), and a literature review on the causal association between COVID-19 and GBS.

conclusionOur two case reports in addition to literature review of 116 published cases may help offer insight into the clinical course of COVID-19 infection. Our two COVID-19 patients presented with neurological manifestations of GBS which were not preceded with any respiratory, gastrointestinal or other systemic infection. This leads us to raise the possibility of establish direct causal association between COVID-19 infection and GBS. Physicians should have high clinical suspicions when encounter GBS patient during the current COVID-19 pandemic and consider co-existence of COVID-19 infection that may warrant SARS-CoV-2 testing, isolation precautions, and specific treatment for Covid-19 infection.

Indexed as

COVID-19Guillain-Barre SyndromeAdultCOVID-19 TestingHumansPandemicsSARS-CoV-2COVID-19Guillain-Barre SyndromeNeurological diseasesNovel coronavirusPeripheral neuropathySARS-CoV-2 infection

Identifiers

PMID34624553
PMCPMC8492388
OpenAlexW3204925880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.